p-methoxy-n-methylphenethylamine has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, R; Qian, J; Qu, Y; Song, N; Wang, Z; Xiong, W; Yang, Y; Zhou, R | 1 |
| Kane, KA; Wainwright, CL; Walsh, SK | 1 |
2 other study(ies) available for p-methoxy-n-methylphenethylamine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation.
Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Cardiotonic Agents; Cell Degranulation; Cell Line; Cell Proliferation; Dexmedetomidine; Hemodynamics; Ischemic Preconditioning; Male; Mast Cells; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; p-Methoxy-N-methylphenethylamine; Rats; Rats, Sprague-Dawley | 2021 |
Mast cell degranulation--a mechanism for the anti-arrhythmic effect of endothelin-1?
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cell Degranulation; Cromolyn Sodium; Disease Models, Animal; Electrocardiography; Endothelin-1; Heart Rate; Histamine Release; Injections, Intravenous; Male; Mast Cells; Myocardial Ischemia; p-Methoxy-N-methylphenethylamine; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation; Ventricular Premature Complexes | 2009 |